Ban on 34 antimicrobials and their formulations for animal use
Final approval of WHO-GMP certificates contingent on State Licensing Authority’s clearance
CDSCO Mandates Strict Testing for Cough Syrups and other formulations Amid Child Death Crisis
CDSCO invites feedback to create a level playing field in new drug approval process
CDSCO Issues Draft Guidance on Medical Device Software Inviting Stakeholder Comments
CDSCO Allows Eli Lilly to Withdraw Covid-19 Indications of Baricitinib in India
Ban on 34 antimicrobials and their formulations for animal use
Final approval of WHO-GMP certificates contingent on State Licensing Authority’s clearance
CDSCO Mandates Strict Testing for Cough Syrups and other formulations Amid Child Death Crisis
CDSCO invites feedback to create a level playing field in new drug approval process
CDSCO Issues Draft Guidance on Medical Device Software Inviting Stakeholder Comments
CDSCO Allows Eli Lilly to Withdraw Covid-19 Indications of Baricitinib in India
